SciELO - Scientific Electronic Library Online

vol.33 issue4Renal tumor with inferior vena cava thrombus: Surgical approach and prognosisCystic displasia of the testis: Review of literature author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Actas Urológicas Españolas

Print version ISSN 0210-4806


FERNANDEZ ARJONA, Manuel et al. Cavernous tisue rehabilitation whit sildenafil 100mg in patients after radical prostatectomy. Actas Urol Esp [online]. 2009, vol.33, n.4, pp.378-385. ISSN 0210-4806.

Objetives: We try to figure out whether early penile rahabilitation ameliorates erectile dysfunction secondary to radical prostatectomy. Material and methods: Retrospective study of 80 cases of patients that were operated between 2005-2008; all of them went under radical prostatectomy and were treated with sildenafil 100mg every second day (Monday , Wednesday and Friday) plus 100mg on demand after the surgery. As objective measurements, we used validated questionnaire IIEF-5 and also axil penile rigidity before and after surgery in the third and ninth month. Results: Patients treated with sildenafil in fixed doses presented a 60% full erection recovery 9 months after radical prostatectomy. In the case where patients underwent bilateral or unilateral nerve sparing, they got a successful rate of almost 90%. Even 20% of those patients who did not have a nerve preservation got satisfactory erections. Conlusions: Our experience shows that early penile rehabilitation seems to be a good treatment for erectile dysfunction after radical prostatectomy with IPDE5 in fixed doses. Administration every other day plus on demand looks like also as an appropriate option.

Keywords : Penile rehabilitation; Radical prostatectomy; Erectyle dysfunction; PDE5 inhibitors.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License